CoChat

Lack of p53 Augments Antitumor Functions in Cytolytic T Cells

Open access
Banerjee, Anirban, Thyagarajan, Krishnamurthy, Chatterjee, Shilpak, Chakraborty, Paramita, Kesarwani, Pravin, Soloshchenko, Myroslawa, Al-Hommrani, Mazen, Andrijauskaite, Kristina, Moxley, Kelly, Janakiraman, Harinarayanan, Scheffel, Matthew J., Helke, Kristi, Armenson, Kent, Palanisamy, Viswanathan, Rubinstein, Mark P., Mayer, Elizabeth-Garrett, Cole, David J., Paulos, Chrystal M., Voelkel-Johnson, Christina, Nishimura, Michael I., Mehrotra, Shikhar · 2016 · Cancer Research
Cited by 38

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Repetitive stimulation of T-cell receptor (TCR) with cognate antigen results in robust proliferation and expansion of the T cells, and also imprints them with replicative senescence signatures. Our previous studies have shown that life-span and antitumor function of T cells can be enhanced by inhibiting reactive oxygen species (ROS) or intervening with ROS-dependent JNK activation that leads to its activation-induced cell death. Because tumor suppressor protein p53 is also a redox active transcription factor that regulates cellular ROS generation that triggers downstream factor–mediating apoptosis, we determined if p53 levels could influence persistence and function of tumor-reactive T cells. Using h3T TCR transgenic mice, with human tyrosinase epitope–reactive T cells developed on p53 knockout (KO) background, we determined its role in regulating antitumor T-cell function. Our data show that as compared with h3T cells, h3T-p53 KO T cells exhibited enhanced glycolytic commitment that correlated with increased proliferation, IFNγ secretion, cytolytic capacity, expression of stemness gene signature, and decreased TGF-β signaling. This increased effector function correlated to the improved control of subcutaneously established murine melanoma after adoptive transfer of p53-KO T cells. Pharmacological inhibition of human TCR-transduced T cells using a combination of p53 inhibitors also potentiated the T-cell effector function and improved persistence. Thus, our data highlight the key role of p53 in regulating the tumor-reactive T-cell response and that targeting this pathway could have potential translational significance in adoptive T-cell therapy. Cancer Res; 76(18); 5229–40. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-15-1798

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 38

Metadata

Authors
Banerjee, A., Thyagarajan, K., Chatterjee, S., Chakraborty, P., Kesarwani, P., Soloshchenko, M., Al-Hommrani, M., Andrijauskaite, K., Moxley, K., Janakiraman, H., Scheffel, M. J., Helke, K., Armenson, K., Palanisamy, V., Rubinstein, M. P., Mayer, E.-G., Cole, D. J., Paulos, C. M., Voelkel-Johnson, C., Nishimura, M. I., & Mehrotra, S.
Venue
Cancer Research
Published
2016-09-15
Volume
76
Issue
18
Pages
5229-5240
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2486957823
Cited by
38
References
8
FWCI
1.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-15-1798
The paper
Banerjee, A., Thyagarajan, K., Chatterjee, S., Chakraborty, P., Kesarwani, P., Soloshchenko, M., Al-Hommrani, M., Andrijauskaite, K., Moxley, K., Janakiraman, H., Scheffel, M. J., Helke, K., Armenson, K., Palanisamy, V., Rubinstein, M. P., Mayer, E.-G., Cole, D. J., Paulos, C. M., Voelkel-Johnson, C., . . . Mehrotra, S. (2016). Lack of p53 Augments Antitumor Functions in Cytolytic T Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-15-1798

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.